Why Heart Disease Research Still Favors Men
Published in partnership with The Fuller Project, a nonprofit newsroom dedicated to the coverage of women’s issues around the world.
Katherine Fitzgerald had just arrived at the party. Before she could even get a drink, she threw up and broke out in a sweat. “I was dizzy. I couldn’t breathe. I had heart pain,” Fitzgerald says.
She knew she was having a heart attack.
[time-brightcove not-tgx=”true”]
What she didn’t know then was that the heart attack could have been prevented. Fitzgerald, a health-conscious, exercise-loving lawyer, should have been taking statin drugs to s...
Source: TIME: Health - April 5, 2024 Category: Consumer Health News Authors: Maggie Fox Tags: Uncategorized freelance healthscienceclimate Source Type: news
Hormonal Birth Control Doesn ’ t Deserve Its Bad Reputation
Almost two-thirds of U.S. women of reproductive age use some kind of contraception, according to the latest federal data. And millions of them use methods that contain hormones, including birth control pills, intrauterine devices (IUDs), rings, implants, injections, and patches.
Although the specifics vary from method to method, hormonal birth control generally works by halting ovulation and/or changing conditions in the uterus or cervix to prevent pregnancy. And it works well: efficacy rates approach 100% when these methods are used correctly.
[time-brightcove not-tgx=”true”]
But hormonal birth control ...
Source: TIME: Health - April 3, 2024 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized Evergreen Explainer healthscienceclimate Source Type: news
The First Over-the-Counter Birth Control Pill Is Here
The first birth control pill that people can buy without a prescription, called Opill, is shipping to stores this week.
Perrigo, the Ireland-based company that makes Opill, said the pills should be available to purchase at retail pharmacies and online by the end of March. The pills are designed to be taken daily at about the same time each day, and they will be sold in one-month packs for $19.99 and three-month packs for $49.99.
[time-brightcove not-tgx=”true”]
A spokesperson for CVS, one pharmacy that will be stocking the pill, said the pills will be in more than 7,500 of its stores nationwide and will ...
Source: TIME: Health - March 4, 2024 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized healthscienceclimate Source Type: news
3 strategies to break down barriers to breastfeeding and lower women ’s risk of breast cancer
Key takeawaysEven though the Affordable Care Act requires coverage of “comprehensive lactation support” families are often unclear about what their insurance offers.Parental leave should be longer and paid for both parents, study participants said.Workplace owners, managers and employees should be better informed about family leave rights.When it comes to encouraging women in California to breastfeed, health care providers, insurance companies and employers need to be doing more, according to recommendations in anew report from theUCLA Center for Health Policy Research.Breastfeeding has been shown in studies tolower th...
Source: UCLA Newsroom: Health Sciences - January 31, 2024 Category: Universities & Medical Training Source Type: news
Post-Breast Cancer Pregnancy Rate Boosted by Egg Freezing: Study
New research is reassuring for young women who want to become pregnant after being treated for breast cancer. (Source: WebMD Health)
Source: WebMD Health - January 23, 2024 Category: Consumer Health News Source Type: news
Pregnancy Safe After BRCA-Mutated Breast Cancer Pregnancy Safe After BRCA-Mutated Breast Cancer
Although pregnancy after breast cancer is considered safe in general, little data exist for BRCA carriers.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 15, 2023 Category: Consumer Health News Tags: Hematology-Oncology Source Type: news
The Unknowns of Taxanes for Breast Cancer During Pregnancy The Unknowns of Taxanes for Breast Cancer During Pregnancy
Taxane exposure during pregnancy appears to be safe for mothers and offspring, according to a new retrospective cohort analysis.MDedge News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - December 12, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news
Avoid Anti-HER2 Cancer Therapies During Pregnancy Avoid Anti-HER2 Cancer Therapies During Pregnancy
Women with HER2-positive breast cancer who receive HER2-targeted therapies during pregnancy face a higher risk for severe adverse outcomes to their fetus or newborn, new research indicates.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - November 29, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
The First Over-the-Counter Birth Control Pill Gets Official Approval
WASHINGTON (AP) — U.S. officials have approved the first over-the-counter birth control pill, which will let American women and girls buy contraceptive medication from the same aisle as aspirin and eyedrops.
The Food and Drug Administration said Thursday it cleared Perrigo’s once-a-day Opill to be sold without a prescription, making it the first such medication to be moved out from behind the pharmacy counter. The company won’t start shipping the pill until early next year, and there will be no age restrictions on sales.
Hormone-based pills have long been the most common form of birth control in the U.S.,...
Source: TIME: Health - July 13, 2023 Category: Consumer Health News Authors: MATTHEW PERRONE / AP Tags: Uncategorized Equality wire Source Type: news
Pausing Endocrine Therapy to Attempt Pregnancy Is Safe Pausing Endocrine Therapy to Attempt Pregnancy Is Safe
The POSITIVE trial provides strong evidence that women with HR-positive early breast cancer can safely interrupt endocrine therapy to try to become pregnant.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 5, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
Temporary Interruption of Endocrine Therapy for Breast Cancer Safe
THURSDAY, May 4, 2023 -- Among select women with previous hormone receptor-positive early breast cancer, there is no increase in the short-term risk for breast cancer events with temporary interruption of endocrine therapy to attempt pregnancy,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 4, 2023 Category: Pharmaceuticals Source Type: news
Breast Cancer Survivors Can Safely Interrupt Therapy During Pregnancy: Study
WEDNESDAY, May 3, 2023 -- For young women who survive breast cancer, a new study offers some reassurance about pregnancy: Pausing hormonal therapy to have a baby does not raise the risk of a cancer recurrence, at least in the shorter term.
A trial... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - May 4, 2023 Category: General Medicine Source Type: news
ERLEADA ® (apalutamide), First-and-Only Next-Generation Androgen Receptor Inhibitor with Once-Daily, Single-Tablet Option, Now Available in the U.S.
HORSHAM, Pa., April 3, 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the availability of an additional tablet strength of ERLEADA® (apalutamide) in the United States. The introduction of the 240mg tablet provides the first-and-only option for a once-daily, single-tablet Androgen Receptor Inhibitor (ARI) approved for the treatment of patients with non-metastatic castration-resistant prostate cancer (nmCRPC) and for the treatment of patients with metastatic castration-sensitive prostate cancer (mCSPC).With two strengths available, healthcare professionals will have the flexibility to...
Source: Johnson and Johnson - April 3, 2023 Category: Pharmaceuticals Tags: Latest News Source Type: news
The Physical Toll Systemic Injustice Takes On the Body
The pathologists who performed Dr. Martin Luther King Jr.’s autopsy noted he had the heart of a 60 year old, although he was 39 when he died. His damaged heart was duly noted in the official record as a curiosity, but there was no question as to the cause of death: homicide; indeed, assassination. A racist hate crime.
But if we were to try to understand the poor condition of his heart, we might be flummoxed. Our general repertoire for understanding the early onset of heart disease points us to demographic and behavioral risk factors like poverty, low education, family breakdown, unhealthy diet, and little exercise. K...
Source: TIME: Health - March 28, 2023 Category: Consumer Health News Authors: Arline T. Geronimus Tags: Uncategorized freelance Race Source Type: news
All Types of Hormonal Birth Control Share a Slightly Increased Risk of Breast Cancer, Study Says
For people who want to prevent pregnancy, birth-control drugs come with an obvious reward. They also come with some small risks—including, for some forms, a slightly increased risk of breast cancer.
This has long been known about the most popular type: combined hormonal birth control, which is available in pill, patch, and ring form. These all contain both estrogen and progestin, a synthetic version of the naturally occurring reproductive hormone progesterone.
Less is known about the breast-cancer risks of progestin-only birth control, a type that’s growing in popularity because it only contains one hormone. B...
Source: TIME: Health - March 21, 2023 Category: Consumer Health News Authors: Haley Weiss Tags: Uncategorized Drugs healthscienceclimate Source Type: news
